[go: up one dir, main page]

Demerson et al., 1983 - Google Patents

Resolution of etodolac and antiinflammatory and prostaglandin synthetase inhibiting properties of the enantiomers

Demerson et al., 1983

Document ID
4508704456042870306
Author
Demerson C
Humber L
Abraham N
Schilling G
Martel R
Pace-Asciak C
Publication year
Publication venue
Journal of medicinal chemistry

External Links

Snippet

Discussion The pharmacological and biochemical results generated with racemic etodolac and with the optically pure enan-tiomers show that most, if not all, of the antiinflammatory activity of etodolac is due to the (+) enantiomer. Similar results have been obtained with …
Continue reading at pubs.acs.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O-metal, -CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Similar Documents

Publication Publication Date Title
Demerson et al. Resolution of etodolac and antiinflammatory and prostaglandin synthetase inhibiting properties of the enantiomers
Kaiser et al. Isomeric inversion of ibuprofen (R)‐enantiomer in humans
Schmid et al. Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
Tanaka et al. The isolation and identification of N-isovalerylglycine from urine of patients with isovaleric acidemia
Gemborys et al. Formation and disposition of the minor metabolites of acetaminophen in the hamster.
CA1271755A (en) Tritium labelled n-mustard type compounds and a process for their production
Roberts et al. Studies on the mode of action of tumour-growth-inhibiting alkylating agents—I: The fate of ethyl methanesulphonate (“half myleran”) in the rat
JPS62267222A (en) Medicine containing unsaturated fatty acid
Rzeszotarski et al. Synthesis and evaluation of radioiodinated derivatives of 1-azabicyclo [2.2. 2] oct-3-yl. alpha.-hydroxy-. alpha.-(4-iodophenyl)-. alpha.-phenylacetate as potential radiopharmaceuticals
Matsuda et al. Inhibition of prostaglandin synthesis by sodium 2-[4-(2-oxocyclopentylmethyl) phenyl] propionate dihydrate (CS-600), a new anti-inflammatory drug, and its active metabolite in vitro and in vivo
Brower et al. Aromatic congeners of bilirubin: synthesis, stereochemistry, glucuronidation and hepatic transport
Jauch et al. Biotransformation of moclobemide in humans
Israili et al. Metabolites of probenecid. Chemical, physical, and pharmacological studies
Bruce et al. Metabolism of metaxalone
Pifferi et al. The cost benefit ratio of enantiomeric drugs
Crawford et al. The metabolism of the pyrethroid insecticide (±)‐α‐cyano‐3‐phenoxybenzyl 2, 2, 3, 3‐tetramethyl‐cyclopropanecarboxylate, WL 41706, in the rat
Shimizu Characterization of an acid hydrolysis product of starfish toxins as a 5. alpha.-pregnane derivative
Lan et al. Metabolism of niflumic acid-14C: absorption, excretion and biotransformation by human and dog
Kubiak et al. Isolation of the key intermediate in the formation of cis-bicyclo [3.3. 0] octane-3, 7-diones from dimethyl 3-ketoglutarate and 1, 2-dicarbonyl compounds
Estas et al. Simultaneous determination of 5, 5-diphenylhydantoin and 5-(p-hydroxyphenyl)-5-phenylhydantoin in serum, urine and tissues by gas—liquid chromatography after flash-heater methylation
Francotte et al. Isolation and stereospecific determination of the enantiomers of oxindazac by direct liquid chromatographic resolution on triacetylcellulose
US3081302A (en) Certain-p-acetaminophenoxyacetamido derivatives
Mohri et al. Stereoselective metabolism of benoxaprofen in rats: biliary excretion of benoxaprofen taurine conjugate and glucuronide
Schirbel et al. [123/131I] Iodometomidate as a radioligand for functional diagnosis of adrenal disease: synthesis, structural requirements and biodistribution
Henderson et al. Metabolism of 4-Methylaminorex (“EU4EA”) in the Rat